A cyberattack on U.S. medical device maker Boston Scientific is causing an ongoing “global disruption” to its operations, according to a federal regulatory filing on Wednesday, the latest healthtech giant to face a cyberattack in recent weeks.
Boston Scientific stock falls as the medical device maker announces the latest batch of bad news for the company.
Boston Scientific stock crumbled Wednesday after the company said a cybersecurity incident interrupted processing and shipping.
Boston Scientific was hit with a cyberattack that is affecting its operations, the company said Wednesday in an SEC filing. The attack is continuing to disrupt the company's ability to ship products, and it's not clear when services will be restored.
Boston Scientific said on Wednesday that a cybersecurity incident had disrupted global operations, including some information systems used to process and ship customer orders.
ALAMEDA, Calif., July 30, 2026 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), the world's leading thrombectomy company, today reported financial results for the second quarter ended June 30, 2026.
Boston Scientific Corp (NYSE:BSX, XETRA:BSX) reported second quarter results that exceeded analyst expectations for revenue and adjusted earnings, while raising its full-year sales outlook. The medical device company posted adjusted earnings per share of $0.86, ahead of the $0.83 consensus estimate, while revenue reached $5.442 billion, compared with analyst expectations of $5.37 billion.